Somany Ceramics is an organized Indian manufacturer of ceramic and glazed vitrified tiles, sanitaryware, bath fittings and construction chemicals, selling largely through a network of about 3,100 dealer showrooms. Tiles remain the core, but bathware and adhesives are the deliberate growth engines, with bathware carrying roughly a 100 basis point EBITDA margin advantage over tiles. The industry is polarized between a handful of branded manufacturers and the unorganized Morbi cluster, estimated at 800 players, many of them small operators with lower first-quality output. Morbi’s cost position has deteriorated because it now has to buy expensive gas from GEL, while Somany passed through a 16-17% tile price increase in early FY27 and retained demand. That pricing power, combined with utilization rising from 72% to 83% year on year in Q1 FY27, took EBITDA margin to 11.6%, a 360 basis point improvement over the prior year. At that level the business is mid-cycle in quality, not exceptional, but the direction is toward the 12% mark management has set.
The persistence of these economics comes less from technology than from distribution density, brand trust and the shifting cost landscape of unorganized supply. Somany uses a legacy network of many small dealers rather than a few large distributors, which gives it stable shelf access in a category where replacement cycles and new building completions drive repeat purchases. Less than a quarter of its tile dealers currently sell bathware or adhesives, so each existing relationship is a low-cost channel to push higher-margin products. On the supply side, 15-17% of Morbi capacity has not restarted and a meaningful part is unlikely to return, while new capacity in the industry is constrained by rupee-dollar uncertainty and gas volatility. Somany has also sourced gas through a basket of contracts, and the organized segment’s pricing gap with Morbi has narrowed as Morbi now pays the same high gas price. These are real but not impenetrable barriers, and the long-run margin will depend on continued utilization gains rather than price power alone.
The inflection is happening now through capacity utilization and JV turnaround, with demand recovery as the second input. Debottlenecking and balancing equipment will add 4-5 million sqm of capacity from mid-Q3 FY27 and fully in Q4 FY27, while a new 9 million sqm greenfield plant in the south, with capex of about INR220 crore, is scheduled to be operational by the end of Q3 or beginning of Q4 FY28 and has a revenue potential of around INR350 crore. Management puts maximum revenue from existing own and JV capacity at roughly INR3,700 crore at today’s prices. Over the next 18-24 months, the most concrete state change is the JV swing: last year the JVs lost INR24-25 crore, and this year they are expected to produce a net profit, an over INR30 crore swing. Somany Max, which lost INR21 crore in FY26 and reached breakeven in Q4 FY26, is guided to a loss of INR10 crore or less in FY27 and profitability in FY27-28. With no major new tile capacity elsewhere and Morbi likely to stay around 85% of pre-disruption output, the organised share gain should translate into mid single-digit tile volume growth and double-digit bathware and adhesive growth.
Management walk-talk is mixed but improving. On the FY26 calls, leadership repeatedly guided to high single-digit revenue growth and 1-1.5 percentage points of EBITDA margin expansion; the actual nine-month revenue growth was about 4% and H1 FY26 margin dipped to 7.9% from 8.5%, so those headline targets were missed. The operational promises, however, have been delivered with more discipline: Somany Max’s quarterly loss narrowed from INR7 crore in Q1 FY26 to INR1 crore in Q1 FY27, and the combined JV line flipped from a INR10 crore loss to a INR3 crore profit in the same quarter. Guidance for FY27 has been upgraded in tone rather than toned down: maintain at least 11.6% EBITDA margin, target 12% or more, mid single-digit volume growth, and double-digit growth in sanitaryware and adhesives. On capital allocation, management has committed to a capex envelope of roughly INR275 crore through FY27, funded 60-70% internally, and to reduce outside debt from INR231 crore to about INR50 crore by FY28. A share buyback is off the table for 6-8 months because of subsidiary consolidation, which is consistent with balance-sheet repair taking priority.
The earnings path is now calculable. If the FY26 EBITDA margin of 9.3% moves to the 12% management target, that is roughly 270 basis points of structural margin expansion, independent of volume; the JV turnaround adds over INR30 crore of pre-tax profit; and debt reduction from INR231 crore to INR50 crore by FY28 lowers finance costs further. For that path to hold, gas prices must remain pass-through, demand must absorb the 16-17% price increases without volume collapse, and utilization must stay near current levels while the debottlenecked capacity comes on line. The single most important watchpoint is the blended gas price and Morbi’s export market: if weak exports push Morbi’s unused output back into the domestic market, or if gas keeps rising faster than pass-through, the 11.6% Q1 EBITDA margin could slip in Q2 or Q3 FY27. The tension between earlier missed revenue targets and the recent margin jump is best read as operational leverage rather than cyclical luck, because the margin gain was driven by utilization and JV performance, not by pricing alone. If those two engines hold, 18-24 months out this will be a higher-margin, lower-debt, more integrated bathware and tiles business with a new southern capacity base.
companyname: Somany Ceramics Limited ticker: SOMANYCERA sector: Ceramics, Tiles, Sanitaryware, Bath Fittings, Building Solutions Somany Ceramics was founded in 1968 and is India's second-largest tile manufacturer (FY26 Annual Report). The company makes ceramic wall and floor tiles, glazed vitrified tiles (GVT), polished vitrified tiles (PVT), and large-format slabs, then layers on sanitaryware, bath fittings, adhesives, and construction chemicals. Tiles are 83.8% of revenue, sanitaryware 6.2%, ...
Read the full report →margin expansion, debt reduction
FY27 EBITDA margin guided to improve by at least 1.5% or more; sanitaryware and adhesives to grow at double-digit rates driven by existing dealership expansion and product mix optimization
Guidance upgradedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Somany Ceramics Limited and 4,900+ companies.
5-day free pass. No card required.